Reintroduction of FOLFOXIRI Plus Bevacizumab After First-Line Progression in Patients With Metastatic Colorectal Cancer – The ASCO Post

By Matthew Stenger Posted: 3/19/2020 11:24:00 AM Last Updated: 3/19/2020 3:45:21 PM In the Italian phase III TRIBE2 trial reported in The Lancet Oncology, Cremolini et al found that reintroduction of FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan) plus…